Skip to search boxSkip to navigationSkip to main content

Utility of a Novel Mobile Lip-Reading Application for Patients After Total Laryngectomy

  • Carly A. Fassler
    ,
  • Shreyas G. Krishnapura
    ,
  • ,
  • Eben Rosenthal
    ,
  • James Netterville
    ,
  • Kyle Mannion
*Corresponding author for this work
Scholary Output:
Contribution to journal
Article
Peer-review

Open access

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

Total laryngectomy (TL) patients have limited options for speech rehabilitation in the immediate postoperative period, resulting in communication difficulties and patient frustration. This study investigates a novel mobile application (app), Speech Recognition Application for the Voice Impaired (SRAVI), to improve postoperative communication for TL patients. Participants received a tutorial on the technology prior to use and had access to the app throughout their hospital admission. A total of 16 patients were included. Of 652 valid transactions within the app, accurate phrase return on the first attempt was 43% with a total accuracy of 67%. Patients used SRAVI primarily to communicate with their care team (66.7%) and with family members/social support (80%). Patients reported using SRAVI, on average, 43.6% of the time to communicate during their hospitalization the majority (69.7%) preferred SRAVI to written communication. In TL patients, use of speech recognition technology is feasible in the immediate postoperative period.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 582-586 (5 pages)

Journal (Volume, Issue Number)

Otolaryngology - Head and Neck Surgery (United States) (Volume 174, Issue 2)

Publication milestones

  • Published - 02/2026

Publication status

Published - 02/2026

ISSN

0194-5998

Publication IDs

  • Scopus: 105026595602
  • PubMed: 41485241

Funding Details

This work was supported by a Vanderbilt Clinical Oncology Research Career Development Program (K12 NCI 2K12CA090625‐22A1).
FunderFunding number
Vanderbilt Clinical Oncology Research Career Development Program
K12 NCI 2K12CA090625‐22A1